MT1002 Phase II Study in ACS Patients With PCI
Clinical trial NCT04723186 · TERMINATED
Trial details
- NCT number
- NCT04723186
- Sponsor
- Shaanxi Micot Pharmaceutical Technology Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-02
- Primary completion
- 2023-08-31
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.